Effect of aerobic exercise training and cognitive behavioural therapy on reduction of chronic fatigue in patients with facioscapulohumeral dystrophy: Protocol of the FACTS-2-FSHD trial

BMC Neurology

Volumn 10, Issue , 2010, Pages

  Voet, Nicoline B M ^a   Bleijenberg, Gijs ^a   Padberg, George W ^b   van Engelen, Baziel G M ^b   Geurts, Alexander C H ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AEROBIC EXERCISE; ARTICLE; BICYCLE ERGOMETRY; CHRONIC FATIGUE SYNDROME; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PHYSIOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; SINGLE BLIND PROCEDURE; THEORETICAL MODEL; TREATMENT DURATION; BIOLOGICAL MODEL; CLINICAL PROTOCOL; CONTROLLED STUDY; HOSPITALIZATION; KINESIOTHERAPY; METHODOLOGY; PSYCHOLOGICAL ASPECT; TIME; TREATMENT OUTCOME;

CLINICAL PROTOCOLS; COGNITIVE THERAPY; EXERCISE THERAPY; FATIGUE SYNDROME, CHRONIC; FOLLOW-UP STUDIES; HUMANS; MODELS, BIOLOGICAL; MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 77954043894     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-10-56     Document Type: Article

References (49)

1. Kissel JT. Facioscapulohumeral dystrophy. Semin Neurol 1999, 19:35-43. 10.1055/s-2008-1040824, 10711987.
2. Padberg GW, Lunt PW, Koch M, Fardeau M. Diagnostic criteria for facioscapulohumeral muscular dystrophy. Neuromuscul Disord 1991, 1:231-234. 10.1016/0960-8966(91)90094-9, 1822799.
3. Tawil R, van der Maarel SM. Facioscapulohumeral muscular dystrophy. Muscle Nerve 2006, 34:1-15. 10.1002/mus.20522, 16508966.
4. Padberg GW, van Engelen BG. Facioscapulohumeral muscular dystrophy. Curr Opin Neurol 2009, 22:539-542. 10.1097/WCO.0b013e328330a572, 19724227.
5. Wohlgemuth M, van der Kooi EL, van Kesteren RG, van der Maarel SM, Padberg GW. Ventilatory support in facioscapulohumeral muscular dystrophy. Neurology 2004, 63:176-178.
6. Quarantelli M, Lanzillo R, Del VW, Mollica C, Prinster A, Iadicicco L, Iodice V, Santoro L. Modifications of brain tissue volumes in facioscapulohumeral dystrophy. Neuroimage 2006, 32:1237-1242. 10.1016/j.neuroimage.2006.04.226, 16806975.
7. Di Lazzaro V, Oliviero A, Tonali PA, Felicetti L, De Marco MB, Saturno E, Pilato F, Pescatori M. Dileone M, Pasqualetti P, Ricci E: Changes in motor cortex excitability in facioscapulohumeral muscular dystrophy. Neuromuscul Disord 2004, 14:39-45. 10.1016/j.nmd.2003.08.002, 14659411.
8. van der Maarel SM, Frants RR, Padberg GW. Facioscapulohumeral muscular dystrophy. Biochim Biophys Acta 2007, 1772:186-194.
9. Lunt PW, Harper PS. Genetic counselling in facioscapulohumeral muscular dystrophy. J Med Genet 1991, 28:655-664. 10.1136/jmg.28.10.655, 1017051, 1941962.
10. Kalkman JS, Schillings ML, van der Werf SP, Padberg GW, Zwarts MJ, van Engelen BG, Bleijenberg G. Experienced fatigue in facioscapulohumeral dystrophy, myotonic dystrophy, and HMSN-I. J Neurol Neurosurg Psychiatry 2005, 76:1406-1409. 10.1136/jnnp.2004.050005, 1739364, 16170086.
11. Engel AG, Franzini-Armstrong C. Myology. 2004,
12. Kalkman JS, Schillings ML, Zwarts MJ, van Engelen BG, Bleijenberg G. The development of a model of fatigue in neuromuscular disorders: a longitudinal study. J Psychosom Res 2007, 62:571-579. 10.1016/j.jpsychores.2006.11.014, 17467412.
13. Horlings CG, Munneke M, Bickerstaffe A, Laverman L, Allum JH, Padberg GW, Bloem BR, van Engelen BG. Epidemiology and pathophysiology of falls in facioscapulohumeral disease. J Neurol Neurosurg Psychiatry 2009, 80:1357-1363. 10.1136/jnnp.2009.173534, 19546106.
14. van der Kooi EL, Kalkman JS, Lindeman E, Hendriks JC, van Engelen BG, Bleijenberg G, Padberg GW. Effects of training and albuterol on pain and fatigue in facioscapulohumeral muscular dystrophy. J Neurol 2007, 254:931-940. 10.1007/s00415-006-0432-4, 2779375, 17361345.
15. Olsen DB, Orngreen MC, Vissing J. Aerobic training improves exercise performance in facioscapulohumeral muscular dystrophy. Neurology 2005, 64:1064-1066.
16. Cup EH, Pieterse AJ, Ten Broek-Pastoor JM, Munneke M, van Engelen BG, Hendricks HT, van der Wilt GJ, Oostendorp RA. Exercise therapy and other types of physical therapy for patients with neuromuscular diseases: a systematic review. Arch Phys Med Rehabil 2007, 88:1452-1464. 10.1016/j.apmr.2007.07.024, 17964887.
17. Voet NB, van der Kooi EL, Riphagen II, Lindeman E, van Engelen BG, Geurts AC. Strength training and aerobic exercise training for muscle disease. Cochrane Database Syst Rev 2010, CD003907.
18. van der Kooi EL, Vogels OJ, van Asseldonk RJ, Lindeman E, Hendriks JC, Wohlgemuth M, van der Maarel SM, Padberg GW. Strength training and albuterol in facioscapulohumeral muscular dystrophy. Neurology 2004, 63:702-708.
19. Van Engelen BG, van VH, Van Doorn PA, Faber CG, van der Hoeven JH, Janssen NG, Notermans NC, van Schaik I, Visser LH, Verschuuren JJ. The Dutch neuromuscular database CRAMP (Computer Registry of All Myopathies and Polyneuropathies): development and preliminary data. Neuromuscul Disord 2007, 17:33-37. 10.1016/j.nmd.2006.09.017, 17141501.
20. Ricci E, Galluzzi G, Deidda G, Cacurri S, Colantoni L, Merico B, Piazzo N, Servidei S, Vigneti E, Pasceri V, Silvestri G, Mirabella M, Mangiola F, Tonali P, Felicetti L. Progress in the molecular diagnosis of facioscapulohumeral muscular dystrophy and correlation between the number of KpnI repeats at the 4q35 locus and clinical phenotype. Ann Neurol 1999, 45:751-757. 10.1002/1531-8249(199906)45:6<751::AID-ANA9>3.0.CO;2-M, 10360767.
21. Vercoulen JH, Swanink CM, Fennis JF, Galama JM, van der Meer JW, Bleijenberg G. Dimensional assessment of chronic fatigue syndrome. J Psychosom Res 1994, 38:383-392. 10.1016/0022-3999(94)90099-X, 7965927.
22. Arnau RC, Meagher MW, Norris MP, Bramson R. Psychometric evaluation of the Beck Depression Inventory-II with primary care medical patients. Health Psychol 2001, 20:112-119. 10.1037/0278-6133.20.2.112, 11315728.
23. Beck AT, Guth D, Steer RA, Ball R. Screening for major depression disorders in medical inpatients with the Beck Depression Inventory for Primary Care. Behav Res Ther 1997, 35:785-791. 10.1016/S0005-7967(97)00025-9, 9256522.
24. Kalkman JS, Schillings ML, Zwarts MJ, van Engelen BG, Bleijenberg G. Influence of relatives on fatigue experienced by patients with facioscapulohumeral dystrophy, myotonic dystrophy and HMSN-I. Eur Neurol 2006, 56:24-30. 10.1159/000095137, 16914927.
25. WHO International Classification of Functioning, Disability and Health (ICF). Geneva 2001, WHO.
26. van der Werf SP, Prins JB, Vercoulen JH, van der Meer JW, Bleijenberg G. Identifying physical activity patterns in chronic fatigue syndrome using actigraphic assessment. J Psychosom Res 2000, 49:373-379. 10.1016/S0022-3999(00)00197-5, 11164063.
27. Vercoulen JH, Bazelmans E, Swanink CM, Fennis JF, Galama JM, Jongen PJ, Hommes O, van der Meer JW, Bleijenberg G. Physical activity in chronic fatigue syndrome: assessment and its role in fatigue. J Psychiatr Res 1997, 31:661-673. 10.1016/S0022-3956(97)00039-3, 9447571.
28. Argov Z, Lofberg M, Arnold DL. Insights into muscle diseases gained by phosphorus magnetic resonance spectroscopy. Muscle Nerve 2000, 23:1316-1334. 10.1002/1097-4598(200009)23:9<1316::AID-MUS2>3.0.CO;2-I, 10951434.
29. Kan HE, Scheenen TW, Wohlgemuth M, Klomp DW, van Loosbroek-Wagenmans I, Padberg GW, Heerschap A. Quantitative MR imaging of individual muscle involvement in facioscapulohumeral muscular dystrophy. Neuromuscul Disord 2009, 19:357-362. 10.1016/j.nmd.2009.02.009, 19329315.
30. Endler NS, Parker JD. Multidimensional assessment of coping: a critical evaluation. J Pers Soc Psychol 1990, 58:844-854. 10.1037/0022-3514.58.5.844, 2348372.
31. Astrand PO, Ryhming I. A normogram for calculation for aerobic capacity (physical fitness) from pulse rate during sub-maximal work. J Appl Physiol 1954, 218-222.
32. Enright PL. The six-minute walk test. Respir Care 2003, 48:783-785.
33. Folstein MF, Luria R. Reliability, validity, and clinical application of the Visual Analogue Mood Scale. Psychol Med 1973, 3:479-486. 10.1017/S0033291700054283, 4762224.
34. Vercoulen JH, Hommes OR, Swanink CM, Jongen PJ, Fennis JF, Galama JM, van der Meer JW, Bleijenberg G. The measurement of fatigue in patients with multiple sclerosis. A multidimensional comparison with patients with chronic fatigue syndrome and healthy subjects. Arch Neurol 1996, 53:642-649.
35. Derogatis LR, Melisaratos N. The Brief Symptom Inventory: an introductory report. Psychol Med 1983, 13:595-605. 10.1017/S0033291700048017, 6622612.
36. Jacobs HM, Luttik A, Touw-Otten FW, de Melker RA. [The sickness impact profile; results of an evaluation study of the Dutch version]. Ned Tijdschr Geneeskd 1990, 134:1950-1954.
37. Cardol M, de Haan RJ, van den Bos GA, de Jong BA, de G I. The development of a handicap assessment questionnaire: the Impact on Participation and Autonomy (IPA). Clin Rehabil 1999, 13:411-419. 10.1191/026921599668601325, 10498348.
38. Aaronson NK, Muller M, Cohen PD, Essink-Bot ML, Fekkes M, Sanderman R, Sprangers MA, te Velde A, Verrips E. Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol 1998, 51:1055-1068. 10.1016/S0895-4356(98)00097-3, 9817123.
39. Bosscher RJ, Smit JH. Confirmatory factor analysis of the General Self-Efficacy Scale. Behav Res Ther 1998, 36:339-343. 10.1016/S0005-7967(98)00025-4, 9642852.
40. Evers AW, Kraaimaat FW, van LW, Jongen PJ, Jacobs JW, Bijlsma JW. Beyond unfavorable thinking: the illness cognition questionnaire for chronic diseases. J Consult Clin Psychol 2001, 69:1026-1036. 10.1037/0022-006X.69.6.1026, 11777106.
41. Post MW, Festen H, van D, Visser-Meily JM. Reproducibility of the Caregiver Strain Index and the Caregiver Reaction Assessment in partners of stroke patients living in the Dutch community. Clin Rehabil 2007, 21:1050-1055. 10.1177/0269215507079140, 17984156.
42. Van Sonderen EL. Sociale Steun Lijst Interacties (SSL-I) en Sociale Steun Lijst Discrepanties (SSL-D). Noordelijk centrum voor gezondheidsvraagstukken 1993,
43. Creamer M, Bell R, Failla S. Psychometric properties of the Impact of Event Scale - Revised. Behav Res Ther 2003, 41:1489-1496. 10.1016/j.brat.2003.07.010, 14705607.
44. van der Ploeg E, Mooren TT, Kleber RJ, van d V, Brom D. Construct validation of the Dutch version of the impact of event scale. Psychol Assess 2004, 16:16-26. 10.1037/1040-3590.16.1.16, 15023089.
45. Prins JB, Bleijenberg G, Bazelmans E, Elving LD, de Boo TM, Severens JL, van der Wilt GJ, Spinhoven P, van der Meer JW. Cognitive behaviour therapy for chronic fatigue syndrome: a multicentre randomised controlled trial. Lancet 2001, 357:841-847. 10.1016/S0140-6736(00)04198-2, 11265953.
46. Andrykowski MA, Schmidt JE, Salsman JM, Beacham AO, Jacobsen PB. Use of a case definition approach to identify cancer-related fatigue in women undergoing adjuvant therapy for breast cancer. J Clin Oncol 2005, 23:6613-6622. 10.1200/JCO.2005.07.024, 2562283, 16170168.
47. Servaes P, Verhagen C, Bleijenberg G. Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions. Eur J Cancer 2002, 38:27-43. 10.1016/S0959-8049(01)00332-X, 11750837.
48. Washburn RA, Zhu W, McAuley E, Frogley M, Figoni SF. The physical activity scale for individuals with physical disabilities: development and evaluation. Arch Phys Med Rehabil 2002, 83:193-200. 10.1053/apmr.2002.27467, 11833022.
49. Ormel J, Kempen GI, Penninx BW, Brilman EI, Beekman AT, van SE. Chronic medical conditions and mental health in older people: disability and psychosocial resources mediate specific mental health effects. Psychol Med 1997, 27:1065-1077. 10.1017/S0033291797005321, 9300512.